Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Catalytic nucleic acids: from lab to applications.

L Q Sun1, M J Cairns, E G Saravolac

  • 1Johnson and Johnson Research Laboratories, Australian Technology Park, Eveleigh, New South Wales, Australia. lsun2@medau.jnj.com

Pharmacological Reviews
|September 8, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Establishing a National SABR Service: A Model for Safe and Effective Clinical Implementation.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Hypogammaglobulinemia and infection rates in patients with multiple sclerosis treated with ocrelizumab for up to six years: A real-world single-center study.

Multiple sclerosis journal - experimental, translational and clinical·2025
Same author

First Constraint on Atmospheric Millicharged Particles with the LUX-ZEPLIN Experiment.

Physical review letters·2025
Same author

New Constraints on Cosmic Ray-Boosted Dark Matter from the LUX-ZEPLIN Experiment.

Physical review letters·2025
Same author

Dark Matter Search Results from 4.2  Tonne-Years of Exposure of the LUX-ZEPLIN (LZ) Experiment.

Physical review letters·2025
Same author

Access arts for refugees: an evaluation.

Perspectives in public health·2025

Catalytic DNA enzymes (deoxyribozymes) show promise for gene inactivation, rivaling ribozymes. Efficient delivery of these DNA enzymes to target RNA in vivo remains a key challenge for clinical applications.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Synthetic Biology

Background:

  • Catalytic nucleic acids, like ribozymes, offer nonprotein catalysts for biomolecule manipulation.
  • Hammerhead and hairpin ribozymes are potent RNA-cleaving enzymes for gene inactivation.
  • RNA modifications enhance ribozyme stability, but 2'OH-group dependence limits their use.

Purpose of the Study:

  • To explore DNA enzymes (deoxyribozymes) as novel catalytic nucleic acids for gene suppression.
  • To compare the efficacy and stability of deoxyribozymes with synthetic ribozymes.
  • To address the challenge of in vivo delivery for deoxyribozyme applications.

Main Methods:

  • In vitro selection to develop DNA enzymes with RNA cleavage activity.
  • In vitro and in vivo studies to assess gene suppression capabilities.

Related Experiment Videos

  • Evaluation of various delivery strategies in animal models.

    • Main Results:

    • Deoxyribozymes exhibit significant RNA cleavage activity, comparable to ribozymes.
    • These DNA enzymes have demonstrated gene suppression potential in both in vitro and in vivo settings.
    • Challenges in intracellular delivery of deoxyribozymes are being actively investigated.

    Conclusions:

    • Deoxyribozymes represent a promising class of catalytic nucleic acids for gene inactivation.
    • Despite limitations in delivery, ongoing research aims to translate deoxyribozyme technology for clinical use.
    • Further development in delivery systems is crucial for the therapeutic application of deoxyribozymes.